Pancreatic cancer is an almost uniformly fatal disease that will strike -33,000 families in the United States this year. It has been estimated that 5-10% of these cancers have a familial basis. A better understanding of the genetic basis for the familial aggregation of pancreatic cancer will form a foundation for counseling patients and their families, a basis for the rational application of new tests to detect this disease earlier, and may lead to gene-specific therapies. This project builds on progress made and collaborations established during the last funding period of this Gl SPORE in which we demonstrated: a) that individuals with a strong family history of pancreatic cancer have a significantly increased risk of developing pancreatic cancer, b) that these at-risk individuals can be screened by endoscopic ultrasound for early neoplasia, c) that this early neoplasia has a distinct phenotype, d) that germ-line mutations in BRCA2 and other members of the Fanconi anemia pathway are associated with an increased risk of developing pancreatic cancer, and e) that cancers with these mutations are selectively sensitive to gene-specific therapies. We now propose to: 1) define the patterns of clustering of pancreatic and non-pancreatic cancers in families and to use these data to develop a risk prediction tool (PancPRO) for clinical use, 2) perform a case-control genome wide association study on familial pancreatic cancer kindreds of Ashkenazi Jewish descent, and 3) determine the gene(s) responsible for the familial clustering of pancreatic cancer. The studies proposed here directly address a research priority identified in the NCI Pancreatic Cancer Program Review Group (PRG) - """"""""Identify genetic factors, environmental factors, and gene-environment interactions that contribute to pancreatic cancer development."""""""" The studies proposed will utilize tissues and families from the Cores (Core 2 and Core 3) to translate genetic discoveries made in Project 1B and 3C to patient care and they will provide a scientific basis for the selection of patients

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA062924-16
Application #
7874598
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
16
Fiscal Year
2009
Total Cost
$178,262
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Kuboki, Yuko; Fischer, Catherine G; Beleva Guthrie, Violeta et al. (2018) Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions. J Pathol :
Zhang, Jiajia; Quadri, Shafat; Wolfgang, Christopher L et al. (2018) New Development of Biomarkers for Gastrointestinal Cancers: From Neoplastic Cells to Tumor Microenvironment. Biomedicines 6:
Hata, Tatsuo; Suenaga, Masaya; Marchionni, Luigi et al. (2018) Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. Am J Pathol 188:1723-1733
Noë, Michaël; Rezaee, Neda; Asrani, Kaushal et al. (2018) Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. Am J Pathol 188:1530-1535
Schunke, Kathryn J; Rosati, Lauren M; Zahurak, Marianna et al. (2018) Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers. Adv Radiat Oncol 3:42-51
Zhang, Jiajia; Wolfgang, Christopher L; Zheng, Lei (2018) Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer. Cancers (Basel) 10:
Dejea, Christine M; Fathi, Payam; Craig, John M et al. (2018) Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359:592-597
Staedtke, Verena; Bai, Ren-Yuan; Kim, Kibem et al. (2018) Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 564:273-277
Deng, Yang; Tu, Huakang; Pierzynski, Jeanne A et al. (2018) Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer 92:20-32
Tamura, Koji; Yu, Jun; Hata, Tatsuo et al. (2018) Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 115:4767-4772

Showing the most recent 10 out of 883 publications